MetabolismModified research peptide
10 mg or 20 mg per vial · research identifier LY3437943
€121.84
no VAT (export: United States), plus shipping
● In stock · Available in this size: 62
Synthetic research peptide. For research and laboratory use only. Not for use in humans or animals.
Triple Agonist is a synthetic, modified research peptide identified as LY3437943. It is used in research involving GIP, GLP-1 and glucagon receptors. Its structure comprises 39 amino acid residues, including non-standard residues and a defined side-chain modification. The listed sizes contain 10 mg or 20 mg per vial. For research and laboratory use only; not for human or animal use.
Store dry at −20 °C, protected from sunlight. After reconstitution, at 2–8 °C.
Shipped from the EU; to Germany with DHL in 1–2 working days. Payment by bank transfer (SEPA): you receive the details with the order confirmation, and we ship once payment has arrived. Shipping rates and times
For research and laboratory purposes only. Not for use in humans or animals, not for diagnostic or therapeutic purposes.
BioXgen Europe supplies research chemicals exclusively for scientific research purposes to persons aged 18 and over.
Important notice: By confirming, you declare that you are 18 years of age or older and are purchasing the products exclusively for scientific research purposes. The products are not intended for human or animal consumption.
